Some 55 attorneys general (AGs), representing all eligible states and US territories, have agreed to sign on to a $7.4 ...

US pharma major Eli Lilly (today announced a definitive agreement to acquire Verve Therapeutics, a Boston-based ...

Australian biotech CSL has announced that the US Food and Drug Administration (FDA) has approved Andembry (garadacimab-gxii), ...

US trade association PhRMA (Pharmaceutical Research and Manufacturers of America) has cited a new IQVIA study that found that ...

South Korea’s clinical-stage biotech D&D Pharmatech saw its share leap as much as 30% as it revealed “remarkably positive” ...

Shares of USA-based NextCure slumped 26% to $0.50 on Monday, after the company announced a strategic partnership with ...

Israel’s Teva Pharmaceutical Industries and Shanghai Fosun Pharmaceutical have entered a strategic partnership for the ...

Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, ...

French drug developer Averoa today announced that the European Commission (EC) has granted marketing authorization for ...

A second case of acute liver failure (ALF) resulting in the death has been reported in a young recipient of Elevidys ...

Scientists at The Institute of Cancer Research, London, claim to have discovered what may cause some treatments to stop working in people living with bowel cancer.

Supernus Pharmaceuticals (Nasdaq: SUPN) is to buy Sage Therapeutics (Nasdaq: SAGE) for total consideration of around $795 million. Shares in Sage shot up by 35% amid the news by midday Monday, while ...